Tibet Rhodiola Pharmaceutical Holding Co. (SHA:600211)

China flag China · Delayed Price · Currency is CNY
41.63
-0.80 (-1.89%)
Mar 9, 2026, 3:00 PM CST
17.93%
Market Cap 13.42B
Revenue (ttm) 2.72B
Net Income (ttm) 981.20M
Shares Out 322.32M
EPS (ttm) 3.04
PE Ratio 13.69
Forward PE n/a
Dividend 1.87 (4.41%)
Ex-Dividend Date n/a
Volume 2,488,936
Average Volume 2,507,995
Open 42.34
Previous Close 42.43
Day's Range 41.57 - 42.34
52-Week Range 34.60 - 57.98
Beta 0.38
RSI 45.73
Earnings Date Mar 13, 2026

About SHA:600211

Tibet Rhodiola Pharmaceutical Holding Co. manufactures pharmaceuticals in China and internationally. The company offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. It also provides capsules, biological preparations, granules, and film-coating agents for cardiovascular, cerebrovascular, hepatobiliary, sprains and contusions, rheumatism, rheumatoid arthritis, colds, and other fields. The company was founded in 1999 and is based in Lhasa, China. [Read more]

Sector Healthcare
Founded 1999
Employees 596
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600211
Full Company Profile

Financial Performance

In 2024, SHA:600211's revenue was 2.81 billion, a decrease of -10.45% compared to the previous year's 3.13 billion. Earnings were 1.05 billion, an increase of 31.26%.

Financial Statements

News

There is no news available yet.